DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

27.83B

Market cap27.83B

Price-Earnings ratio

30.75

Price-Earnings ratio30.75

Dividend yield

—

Dividend yield—

Average volume

8.32M

Average volume8.32M

High today

$73.05

High today$73.05

Low today

$71.31

Low today$71.31

Open price

$71.91

Open price$71.91

Volume

6.37M

Volume6.37M

52 Week high

$89.98

52 Week high$89.98

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $71.60, giving the company a market capitalization of 27.83B. It carries a P/E multiple of 30.75.

On 2026-05-22, DexCom(DXCM) stock moved within a range of $71.31 to $73.05. With shares now at $71.60, the stock is trading +0.4% above its intraday low and -2.0% below the session's peak.

Trading volume for DexCom(DXCM) stock has reached 6.37M, versus its average volume of 8.32M.

The stock's 52-week range extends from a low of $54.11 to a high of $89.98.

DXCM News

Nasdaq 1d

DexCom Takes Over #331 Spot From First Solar

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, DexCom Inc (Symbol: DXCM) has taken over the #331 spot...

Simply Wall St 1d

DexCom Tests Wider Type 2 CGM Adoption With German Dexcom Flex Launch

DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a continuous glucose monitoring system for adults with Type 2 diabetes in Germany. The system is aimed at pati...

Nasdaq 3d

DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany

DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for adults with Type 2 diabetes who are not...

Analyst ratings

84%

of 32 ratings

Buy

84.4%

Hold

12.5%

Sell

3.1%

More DXCM News

TipRanks 4d

DexCom announces Dexcom Flex in Germany

DexCom (DXCM) announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin therapy. The new...

Nasdaq 6d

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose...

Simply Wall St 7d

Is It Time To Revisit DexCom After Share Price Weakness And DCF Upside?

Wondering if DexCom at around US$61.63 is starting to look interesting again, or if the stock still carries too much downside risk for your portfolio? The shar...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.